Yingbei Chen

28PUBLICATIONS
121CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedMolecular targetsCancer cell biologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Dec 11, 2025
Clinical and Molecular Characterization of KRAS-Mutated Renal Cell Carcinoma.

Andrea Lopez Sanmiguel, Yash S Khandwala, Kuo Fengshen

|Feb 25, 2025
Immune Checkpoint Blockade Response in Mucinous Tubular and Spindle Cell Carcinoma.

Simran Makker, Neil J Shah, Maria I Carlo

|Jun 26, 2023
Interferon signaling promotes tolerance to chromosomal instability during metastatic evolution in renal cancer.

Luigi Perelli, Federica Carbone, Li Zhang

|Dec 23, 2022
Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.

Joshua I Warrick, Wenhuo Hu, Hironobu Yamashita

|Nov 03, 2022
FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.

Joshua I Warrick, Wenhuo Hu, Hironobu Yamashita

|Oct 27, 2022
Renal Medullary Carcinomas Harbor a Distinct Methylation Phenotype and Display Aberrant Methylation of Genes Related to Early Nephrogenesis.

Victoria E Fincke, Mateja E Krulik, Piyush Joshi

Pageof 5

Frequent Collaborators

6 joint publications

Martin H Voss

6 joint publications

James J Hsieh

6 joint publications

Robert J Motzer

6 joint publications

Fengshen Kuo